Hanmi, Sanofi-Aventis Korea announce partnership
Under the deal, Sanofi-Aventis Korea will be in charge of selling Hanmi’s combination drug (irbersartan/atorvastatin tablets) when Hanmi completes Phase III clinical...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
